This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. OCGN were unchanged Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.59% to 3,959.90 and the Dow Jones Industrial Average DJIA rising 0.15% to 31,874.84. Ocugen Inc. closed $14.94 below its 52-week high ($17.65), which the company achieved on November 3rd.
The stock underperformed when compared to some of its competitors Wednesday, as Adverum Biotechnologies Inc. ADVM rose 1.75% to $1.74, Ocular Therapeutix Inc. OCUL rose 5.01% to $4.61, and Kodiak Sciences Inc. KOD rose 2.05% to $9.94. Trading volume (6.1 M) remained 794,403 below its 50-day average volume of 6.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 20, 2022.
(END) Dow Jones Newswires
July 20, 2022 17:12 ET (21:12 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.